Auranofin Completed Phase 2 Trials for Pain Supportive Care

IndicationsStatusPurposePhase
CompletedSupportive Care2
clinicaltrials.gov IdentifierTitleDrugs
NCT02063698Auranofin in Decreasing Pain in Patients With Paclitaxel-Induced Pain Syndrome